The role of p53 and autophagy in Dasatinib resistance of CLL lymphocytes.
Pitini
Vincenzo V
VV
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001343:Autophagy; D000069439:Dasatinib; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000473:pathology; D011743:Pyrimidines / Q000627:therapeutic use*; D013844:Thiazoles / Q000627:therapeutic use*; D016159:Tumor Suppressor Protein p53 / Q000502:physiology*
D000970:Antineoplastic Agents; D011743:Pyrimidines; D013844:Thiazoles; D016159:Tumor Suppressor Protein p53; D000069439:Dasatinib